Controlled Release Drug Delivery Market, By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others (Micro-electromechanical Technology and Liposomes)), By Release Mechanism (Polymer Matrix Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, and Chemically Activated), By Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, and Drug Eluting Stents) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI103719 | Publish Date: May 2024 | No. of Pages: 180

Global Controlled Release Drug Market Companies

  • Depomed, Inc
  • Coating Place, Inc.
  • Corium International Inc.
  • Alza Corporation (Johnson & Johnson)
  • Alkermes plc
  • Pfizer Inc.
  • SKY Pharmaceuticals Pvt. Ltd.
  • Pfizer, Inc
  • Aradigm Corporation
  • Capsugel Healthcare Pvt Ltd

Recent News:

  • In April 2024, DifGen Pharmaceuticals LLC ("DifGen") announced today that it has acquired Aveva Drug Delivery Services Inc. ("Aveva") a fully integrated developer and manufacturer of Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF). The acquisition of Aveva Drug Delivery Services Inc with its 300 plus employees marks an important milestone for DifGen as it adds its first pharmaceutical manufacturing base in the US. This strategic investment allows the company to expand our R&D & manufacturing capabilities in offering complex dosage forms and secure supply to valuable partners with local US based manufacturing. Most importantly, it will provide patients affordable lifesaving medication with highest quality and consistent supply.